Mitrabahtera Segara Sejati Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Mitrabahtera Segara Sejati Tbk. trades at Rp2,620 (market cap 4.41T, 684.2K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,590 (market cap 11.36T, 1.77M 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 2.6× Mitrabahtera Segara Sejati Tbk.'s market cap, and Tempo Scan Pacific Tbk. is more actively traded (1.77M versus 684.2K). Which is the better fit depends on your goals.
| MBSS | TSPC | |
|---|---|---|
Market Cap | 4.41T | 11.36T |
Volume | 684.2K | 1.77M |
Lot | 6.84K | 17.71K |
Turnover | 1.78B | 4.61B |
Average Price | 2,599.41 | 2,603.9 |
Value | 1.78B | 4.61B |
Indicative Equilibrium Price | 2,620 | 2,590 |
Indicative Equilibrium Volume | 33 | 300 |
Trailing returns across standard periods
Latest headlines on both assets
PT Mitrabahtera Segara Sejati Tbk (the company) was established on 24 Mar 1994 based on Notaries Deed No. 107 and the deed of establishment was approved by the the Ministry of Justice dated Nov 6, 1996. The Company’s articles of association has been amended several times, most recently by notarial deed No. 5 of Fathiah Helmi, S.H., dated Dec 13, 2010, concerning among others, the change in the Company’s name, and public offering.
Read more on MBSS →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →